Posts in Trade Secrets
Cheekd Follow-Up: Pirri Responds, Cheek Implores Nadler to Help Curb U.S. Patent Abuses
Earlier this week we reported on Lori Cheek, an independent inventor who is defending herself for the second time against accusations brought by Alfred Pirri, Jr. of …
Other Barks & Bites for Friday, April 12: Global Music Copyright Revenues Up, Copyright Office Examines Online Infringement Issues, and China’s ‘Reverse Patent Troll’ Problem
This week in other IP news, recently released data shows that worldwide revenues for music copyright exceeded $28 billion in 2017, up $2 billion over 2016; reports surface about the “reverse …
Scott Elmer, St. Jude Children’s Research Hospital On the ‘Sea Change’ in Diagnostics Patent Strategies
Scott Elmer is Director, Office of Technology Licensing, at St. Jude Children’s Research Hospital, one of the leading pediatric cancer hospitals in the country. The institution …
A Lack of Focus on Trade Secrets Can Pose Serious Risks
We all talk about the importance of data as business assets, but when it comes to buying and selling the companies that own them, we seem not …
Other Barks & Bites for Friday, March 22: Vanda Action at Supreme Court, Apple Has to Pay, and Senators Express Concerns Over Fourth Estate
This week in Other Barks & Bites: the Supreme Court asks for the U.S. Solicitor General’s view on whether patents that claim a method of medically …
Congressman Steve Stivers on the STRONGER Patents ACT, USPTO Reforms, and the State of U.S. Innovation
Representative Steve Stivers (R-OH) and Representative Bill Foster (D-IL) introduced the Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act, which would …
Lighthizer’s Double Challenge: Protecting IP by Managing Both China and Trump
While a preliminary trade deal seems to have been struck between China and the United States over tariffs, the two sides have yet to seriously address the …
Up and Running: Senate IP Subcommittee Debates USPTO Oversight After Setting Ambitious Agenda in February
Today, March 13, the Senate Subcommittee on Intellectual Property met to discuss “Oversight of the United States Patent and Trademark Office,” with USPTO Director Andrei Iancu as the …
Post-Myriad Legal and Policy Considerations for Patenting Genetic Inventions
The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context …
Why it May Be Time to Provide Criminal Remedies for Patent Infringement
Under normal circumstances, infringement and misappropriation of the intellectual property (IP) rights of others are subject to civil liability under U.S. federal (and some states’) law; …
Of Secret Sales and Public Uses: The Practical Consequences of the Supreme Court’s Helsinn Decision
It seemed like a trade secret trifecta when Congress in 2011 passed the America Invents Act (AIA). Although the statute was aimed at patent reform, it made three …
Don’t Be Fooled by His Patent Purge: Elon Musk is Just Another Hypocritical Tech Billionaire
In 2014, Elon Musk made Tesla’s patents available for anyone to use for free, stating that “technology leadership is not defined by patents.” Earlier this month, Musk …
IP and Innovation on Capitol Hill: Week of February 11
This week on Capitol Hill, the Democrat-controlled House of Representatives has planned a number of hearings on climate change and antitrust matters, especially where the T-Mobile/Sprint …
Why Helsinn v. Teva Creates Inscrutable Uncertainty About the Scope of Prior Art Instead of Confirming Longstanding Law
To the casual observer, the Supreme Court’s January 23 decision in Helsinn v. Teva may seem like no big deal. In just a few pages of text, …
IP and Innovation on Capitol Hill: Week of February 4
This week on Capitol Hill, committee hearings in the U.S. Senate will focus on innovations related to financial systems, the race to 5G network connectivity and …
